Organogenesis Holdings Inc - Class A
Sector: Professional, Scientific, and Technical Services
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
2.98
0.01
(0.337%)
Volume:
631,429
52 week range:
1.8 - 4.71
Market Cap:
393.25M
Company Description:
headquartered in canton, massachusetts, organogenesis inc. is a global leader in regenerative medicine, offering a portfolio of bioactive and acellular biomaterials products in advanced wound care and surgical biologics, including orthopedics and spine. organogenesis’ versatile portfolio is designed to treat a variety of patients with repair and regenerative needs.